We are live on
!
Find out more
GA
Geneva Advisors Portfolio holdings
AUM
$5.81B
Turnover
22.5%
1-Year Est. Return
23.71%
This Fund
S&P 500
This Quarter
Est. Return
+0.1%
1 Year Est. Return
+23.71%
3 Year Est. Return
+53.12%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$4.97B
AUM Growth
-$227M
(-4.4%)
Cap. Flow
-$120M
Cap. Flow
% of AUM
-2.42%
Top 10 Holdings %
Top 10 Hldgs %
24.91%
Holding
802
New
109
Increased
252
Reduced
267
Closed
54
Avg Time Held
1.6
years
Top 10 Avg Time Held
1.1
years
Top 20 Avg Time Held
0.8
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Ventas
VTR
|
+$29.1M |
| 2 |
Bristol-Myers Squibb
BMY
|
+$28.3M |
| 3 |
Ecolab
ECL
|
+$25.4M |
| 4 |
Merck
MRK
|
+$24.7M |
| 5 |
Edwards Lifesciences
EW
|
+$20.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ServiceNow
NOW
|
+$44M |
| 2 |
SBA Communications
SBAC
|
+$43.3M |
| 3 |
Chipotle Mexican Grill
CMG
|
+$42M |
| 4 |
TD Ameritrade Holding Corp
AMTD
|
+$40.5M |
| 5 |
Gilead Sciences
GILD
|
+$39.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 18.75% |
| 2 | Consumer Discretionary | 15.42% |
| 3 | Technology | 15.27% |
| 4 | Financials | 12.99% |
| 5 | Industrials | 8.44% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
126
Qualcomm
QCOM
$191B
| $4.03M | 0.08% |
78,789
+15,337
| +24% | +$748K |
2013 Q2
11 quarters
|
|
127
Yum! Brands
YUM
$41.2B
| $3.98M | 0.08% |
67,657
+13,917
| +26% | +$730K |
2013 Q2
11 quarters
|
|
128
IBM
IBM
$221B
| $3.97M | 0.08% |
27,439
+951
| +4% | +$121K |
2013 Q2
11 quarters
|
|
129
Plains All American Pipeline
PAA
$17.7B
| $3.96M | 0.08% |
189,077
-7,918
| -4% | -$167K |
2013 Q2
11 quarters
|
|
130
lululemon athletica
LULU
$11.5B
| $3.94M | 0.08% |
58,234
+4,561
| +8% | +$274K |
2013 Q3
10 quarters
|
|
131
Euronet Worldwide
EEFT
$2.45B
| $3.82M | 0.08% |
51,507
-23,566
| -31% | -$1.66M |
2013 Q3
10 quarters
|
|
132
DELISTED
Dominion Energy Midstream Ptr LP
DM
| $3.75M | 0.08% |
111,265
+5,255
| +5% | +$156K |
2014 Q4
5 quarters
|
|
|
NORD
133
DELISTED
Nord Anglia Education, Inc.
NORD
| $3.7M | 0.07% |
177,189
-91,189
| -34% | -$1.67M |
2014 Q1
8 quarters
|
|
134
Accenture
ACN
$138B
| $3.66M | 0.07% |
31,719
-699
| -2% | -$71.8K |
2013 Q2
11 quarters
|
|
135
Wells Fargo
WFC
$248B
| $3.66M | 0.07% |
75,670
+1,791
| +2% | +$87.7K |
2013 Q2
11 quarters
|
|
|
SHLX
136
DELISTED
Shell Midstream Partners, L.P.
SHLX
| $3.64M | 0.07% |
99,320
+390
| +0.4% | +$13.7K |
2014 Q4
5 quarters
|
|
137
Altria Group
MO
$123B
| $3.29M | 0.07% |
52,584
+2,045
| +4% | +$124K |
2013 Q2
11 quarters
|
|
138
Oracle
ORCL
$408B
| $3.26M | 0.07% |
79,708
+526
| +0.7% | +$19.5K |
2013 Q2
11 quarters
|
|
139
Verizon
VZ
$184B
| $3.23M | 0.07% |
59,733
+4,847
| +9% | +$242K |
2013 Q2
11 quarters
|
|
140
O'Reilly Automotive
ORLY
$71.6B
| $3.09M | 0.06% |
169,410
-165
| -0.1% | -$2.82K |
2013 Q2
11 quarters
|
|
141
DELISTED
Du Pont De Nemours E I
DD
| $3M | 0.06% |
47,342
-1,192
| -2% | -$71.3K |
2013 Q2
11 quarters
|
|
|
AGN
142
DELISTED
Allergan plc
AGN
| $2.97M | 0.06% |
11,090
-2,903
| -21% | -$831K |
2013 Q2
11 quarters
|
|
143
Vanguard Morningstar Small-Cap ETF
VB
$77.9B
| $2.97M | 0.06% |
26,630
+4,470
| +20% | +$463K |
2014 Q1
8 quarters
|
|
|
ESRX
144
DELISTED
Express Scripts Holding Company
ESRX
| $2.88M | 0.06% |
41,883
-128
| -0.3% | -$9.2K |
2013 Q2
11 quarters
|
|
145
Novo Nordisk
NVO
$173B
| $2.81M | 0.06% |
103,666
-14,080
| -12% | -$377K |
2014 Q2
7 quarters
|
|
146
Oneok
OKE
$57.1B
| $2.77M | 0.06% |
92,842
-2,298
| -2% | -$56.6K |
2013 Q2
11 quarters
|
|
147
iShares MSCI Emerging Markets ETF
EEM
$29.6B
| $2.77M | 0.06% |
80,758
+4,560
| +6% | +$141K |
2013 Q2
11 quarters
|
|
148
Kimberly-Clark
KMB
$34.6B
| $2.73M | 0.05% |
20,260
+311
| +2% | +$40.5K |
2013 Q2
11 quarters
|
|
149
Genesis Energy
GEL
$1.7B
| $2.72M | 0.05% |
85,440
+3,780
| +5% | +$105K |
2013 Q2
11 quarters
|
|
150
Aemetis
AMTX
$105M
| $2.69M | 0.05% |
1,316,571
+52,175
| +4% | +$103K |
2014 Q2
7 quarters
|
|
Similar funds
CAM
DL
TCM
HCM
AL
AT
Geneva Advisors's Q1 2016 Portfolio in Review
As of Q1 2016, Geneva Advisors held 802 positions worth $4.97B, down 4.4% from $5.2B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Geneva Advisors's Q1 2016 filing shows 109 new, 252 increased, 267 reduced and 54 closed positions. Its largest new stake was Ventas: 517,036 shares worth $32.6M. The largest sale was ServiceNow, an estimated $44M.
By sector, the portfolio is most concentrated in Healthcare at 19% of assets, down from 19% a quarter earlier, followed by Consumer Discretionary and Technology.
- Geneva Advisors's largest Q1 2016 buy was Ventas: 517,036 shares worth $32.6M.
- Geneva Advisors added most to Bristol-Myers Squibb in Q1 2016, an estimated $28.3M increase.
- Geneva Advisors's biggest Q1 2016 reduction was SBA Communications, cutting an estimated $43.3M.
- Geneva Advisors fully exited ServiceNow in Q1 2016, selling an estimated $44M.
- Geneva Advisors's ten largest holdings make up 25% of its $4.97B portfolio in Q1 2016.
- Geneva Advisors opened 109 new positions and closed 54 in Q1 2016.
- Geneva Advisors's portfolio value fell 4.4% quarter-over-quarter to $4.97B.
Based on Geneva Advisors's 13F filing for Q1 2016, filed 3 May 2016.